DI SCALA, GERARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.763
EU - Europa 1.039
AS - Asia 271
AF - Africa 4
OC - Oceania 4
Totale 3.081
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.759
RU - Federazione Russa 491
IT - Italia 180
IE - Irlanda 124
SE - Svezia 90
SG - Singapore 77
HK - Hong Kong 72
PL - Polonia 66
CN - Cina 58
CH - Svizzera 34
IN - India 24
JO - Giordania 21
DE - Germania 16
FI - Finlandia 10
GB - Regno Unito 10
ID - Indonesia 9
VN - Vietnam 6
AT - Austria 5
FR - Francia 5
AU - Australia 4
CI - Costa d'Avorio 4
UA - Ucraina 4
CA - Canada 3
KR - Corea 3
NL - Olanda 2
CR - Costa Rica 1
ES - Italia 1
HU - Ungheria 1
TR - Turchia 1
Totale 3.081
Salva come PNG Salva come JPEG
Città #
Santa Clara 558
Fairfield 171
Dublin 124
Ashburn 113
Chandler 110
Seattle 84
Houston 76
Woodbridge 76
Warsaw 66
Singapore 64
Lawrence 53
Altamura 52
Cambridge 52
Wilmington 51
Hong Kong 43
Bern 33
Moscow 32
Buffalo 30
Princeton 30
Florence 29
Boston 26
Ann Arbor 22
Mumbai 22
Shanghai 18
Beijing 15
New York 14
Boardman 13
San Diego 11
Kent 10
Rome 10
Helsinki 9
Jakarta 9
Bologna 7
Falls Church 7
Medford 7
Redwood City 7
Dong Ket 6
Milan 6
Los Angeles 5
Norwalk 5
Vienna 5
Abidjan 4
Hillsboro 4
Jinan 4
Melbourne 4
Napoli 4
Washington 4
Bari 3
Guangzhou 3
London 3
Padova 3
Redmond 3
Rieti 3
Yubileyny 3
Andover 2
Capannori 2
Castelliri 2
Naaldwijk 2
Pesaro 2
Rho 2
Romainville 2
Saint-Fons 2
Seoul 2
Taiyuan 2
Taizhou 2
Toronto 2
Acton 1
Arezzo 1
Bad Kreuznach 1
Barletta 1
Budapest 1
Esslingen am Neckar 1
Falkenstein 1
Forlì 1
Frankfurt am Main 1
Hefei 1
Hounslow 1
Jining 1
Lappeenranta 1
Laurel 1
Leawood 1
Misano Adriatico 1
Montespertoli 1
Montréal 1
Munich 1
New Bedfont 1
New Delhi 1
Ourton 1
Pisa 1
Pune 1
Rui'an 1
San José 1
St Petersburg 1
Trumbull 1
Wandsworth 1
Xian 1
Yiwu 1
Totale 2.181
Salva come PNG Salva come JPEG
Nome #
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 170
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 149
Practice parameters for sublingual immunotherapy 143
Intravenous immunoglobulin therapy: a snapshot for the internist. 130
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 128
Behçet's syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects 121
The Presence of Uveitis Is Associated With a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 115
Long-term effectiveness and safety of secukinumab for treatment of refractory mucosal and articular Behçet's phenotype: A multicentre study 110
Efficacy of the anti-IL 17 secukinumab in refractory Behçet's syndrome: A preliminary study 109
Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies 106
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 104
Predictors of Sustained Clinical Response in Patients With Behçet's Disease-Related Uveitis Treated With Infliximab and Adalimumab 102
The right place of interleukin-1 inhibitors in the treatment of Behçet’s syndrome: a systematic review 101
Vascular Behçet's syndrome: an update 97
Comparison of treatments for the prevention of fetal growth restriction in obstetric antiphospholipid syndrome: a systematic review and network meta-analysis 96
Erratum: Management of adult-onset Still's disease with interleukin-1 inhibitors: Evidence- And consensus-based statements by a panel of Italian experts 95
null 94
Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet's disease 92
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 92
Behçet's disease as a cause of cerebral sinus vein thrombosis: an emerging role 91
Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: A cross-sectional study 82
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 82
Prompt Clinical Response to Secukinumab in Patients With Axial Spondyloarthritis: Real Life Observational Data From Three Italian Referral Centers 81
Prevalence and clinical associations of ultrasound-confirmed enthesitis in systemic lupus erythematosus 76
Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis 76
Different Drug Survival of First Line Tumour Necrosis Factor Inhibitors in Radiographic and Non-Radiographic Axial Spondyloarthritis: A Multicentre Retrospective Survey 76
Clinical profile and evolution of patients with juvenile-onset Behçet’s syndrome over a 25-year period: insights from the AIDA network 75
Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease 74
Low-dose tocilizumab for relapsing giant cell arteritis in the elderly, fragile patient: Beyond the GiACTA trial 68
Subclinical and Clinical Atherosclerosis in Rheumatoid Arthritis: Results From the 3-year, Multicentre, Prospective, Observational GIRRCS (Gruppo Italiano Di Ricerca in Reumatologia Clinica E Sperimentale) Study 66
Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4) 65
ROS-driven structural and functional fibrinogen modifications are reverted by interleukin-6 inhibition in Giant Cell Arteritis 59
Totale 3.125
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.684
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.684
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020257 0 0 0 0 0 0 54 48 54 30 31 40
2020/2021304 26 27 21 26 55 26 12 13 36 25 23 14
2021/2022235 1 8 32 12 2 12 3 30 14 10 47 64
2022/2023595 54 164 20 14 30 88 71 29 62 8 17 38
2023/2024283 12 24 37 19 24 40 16 53 4 18 15 21
2024/20251.279 61 180 76 299 488 175 0 0 0 0 0 0
Totale 3.125